Blood Pressure Monitoring Devices Market Size & Growth Forecast 2027–2036, By Segments (End Use, Device Type, Connectivity), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Blood Pressure Monitoring Devices Market size was valued at USD 4.6 billion in 2026 and is anticipated to grow at a 8.84% CAGR from 2027 to 2036, attaining USD 10.73 billion by 2036. The industry revenue for 2027 is assessed at USD 4.94 billion.

• Base Year Value (2026): USD 4.6 billion
• CAGR (2027-2036): 8.84%
• Forecast Year Value (2036): USD 10.73 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Blood Pressure Monitoring Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 37.92% market share in 2026, supported by strong home monitoring adoption, established screening practices, mature healthcare systems, and broad availability of connected devices.
  • Asia Pacific is projected to grow at an 11.07% CAGR, fueled by rising hypertension detection, expanding healthcare access, and increasing consumer adoption of affordable digital blood pressure monitors for home use.

• Segment Momentum:

  • Non-Smart/Traditional devices lead the market due to their broad familiarity, ease of use, and established role in routine blood pressure measurement across both clinical and personal monitoring settings.
  • Smart devices are the fastest-growing segment because they support connected health management and ongoing tracking. Their ability to integrate monitoring with digital care routines is increasing adoption among users seeking accessible health data.

• Market Expansion Drivers:

  • Rising hypertension prevalence driven by sedentary lifestyles and aging populations.
  • Expansion of hospital-based monitoring and integrated diagnostic solutions.
  • Growth of home-based remote patient monitoring and connected healthcare ecosystems.

• Leading Market Participants:

  Major players in the blood pressure monitoring devices market include Omron Healthcare Co., Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Welch Allyn, Inc. (United States), A&D Company, Limited (Japan), SunTech Medical, Inc. (United States), Microlife Corporation (Taiwan), Rossmax International Ltd. (Taiwan), Spacelabs Healthcare, Inc. (United States), B. Braun SE (Germany).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 4.6 billion
  • 2027 Estimated Market Size: USD 4.94 billion.
  • Projected Market Size: USD 10.73 billion by 2036
  • Growth Forecasts: 8.84% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End Use) | Non-Smart/Traditional (Device Type) | Non-Connected (Connectivity)
  • Emerging Opportunity Segment: Homecare (End Use) | Smart (Device Type) | Connected (Connectivity)

Market Growth Drivers and Industry Trends

Rising hypertension prevalence driven by sedentary lifestyles and aging populations

Increasing hypertension prevalence associated with aging demographics, reduced physical activity, and lifestyle-related risk factors is creating sustained demand for regular blood pressure assessment, supporting growth in the blood pressure monitoring devices market. Older adults are particularly likely to require repeated measurements because blood pressure management often involves long-term observation and treatment adjustments. At the same time, greater awareness of cardiovascular risk is encouraging more frequent screening among broader population groups, expanding the use of blood pressure measurement devices across clinical settings, pharmacies, community health programs, and individual households.

Expansion of hospital-based monitoring and integrated diagnostic solutions

Hospitals are increasingly adopting monitoring technologies that can provide reliable blood pressure measurements as part of broader diagnostic and patient observation workflows, strengthening the blood pressure monitoring devices market. Blood pressure assessment is routinely incorporated into emergency care, inpatient monitoring, surgical procedures, and chronic disease evaluation, creating demand for devices that can operate efficiently alongside other clinical systems. Integration with multiparameter monitors and electronic clinical workflows can also streamline the collection and interpretation of vital signs, allowing healthcare professionals to assess blood pressure alongside other physiological indicators during patient evaluation.

Growth of home-based remote patient monitoring and connected healthcare ecosystems

The expansion of connected healthcare is moving blood pressure measurement beyond clinical environments, as home-based monitoring becomes an important component of long-term disease management and follow-up care. This trend will boost blood pressure monitoring devices market demand by enabling patients to record measurements regularly and share readings with healthcare professionals through connected platforms. Wireless connectivity, smartphone integration, and remote data access can support more consistent monitoring while helping clinicians identify changes between appointments, particularly for patients managing hypertension over extended periods.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising hypertension prevalence driven by sedentary lifestyles and aging populations	2.40%	High	North America, Europe	High	Near Term
Expansion of hospital-based monitoring and integrated diagnostic solutions	2.10%	Moderate	North America, Asia Pacific	High	Mid Term
Growth of home-based remote patient monitoring and connected healthcare ecosystems	1.80%	Moderate	North America, Asia Pacific	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the blood pressure monitoring devices market, North America accounted for the largest share of 37.92% in 2026. High awareness of cardiovascular health, established healthcare systems, and widespread use of home-based monitoring devices support the region’s strong market position. Increasing emphasis on preventive healthcare and routine blood pressure management is encouraging demand among both healthcare professionals and consumers. Technological advancements in connected and digital monitoring solutions are further supporting adoption by enabling convenient tracking and improved integration of patient data into healthcare management.

Asia Pacific is experiencing the fastest growth, driven by expanding healthcare access, increasing awareness of hypertension management, and the gradual shift toward preventive and home-based care. Improvements in healthcare infrastructure and greater availability of affordable monitoring technologies are broadening access to blood pressure measurement. Growing adoption of digital health tools and increasing demand for convenient self-monitoring are also creating favorable conditions for market expansion across the region.

Key Country Insights

United States

Home Health Expansion

In the U.S., blood pressure monitoring devices are increasingly used in home-based chronic care management and telehealth programs. Manufacturers are emphasizing connected devices that integrate with mobile apps and healthcare platforms to support continuous cardiovascular tracking.

Japan

Self-Monitoring Culture

Japan demonstrates strong adoption of daily self-monitoring practices, with blood pressure devices widely used for routine health tracking. Manufacturers in Japan prioritize compact design, ease of use, and long-term reliability for elderly consumers.

South Korea

Digital Health Tracking

South Korea integrates blood pressure monitoring devices into broader digital wellness ecosystems, with strong uptake of app-connected devices. Healthcare providers in South Korea encourage continuous monitoring to support early detection of hypertension risks.

Germany

Preventive Health Adoption

Germany focuses on preventive cardiovascular care, driving consistent use of clinically validated blood pressure monitoring devices in both primary care and home settings. Healthcare providers in Germany emphasize accuracy standards and integration with digital health records.

France

Primary Care Integration

France emphasizes the use of blood pressure monitoring devices within primary care and pharmacy-led health screening programs. Device adoption in France is supported by increasing focus on early diagnosis and routine cardiovascular assessment.

Italy

Community Health Monitoring

Italy is expanding blood pressure monitoring use through community healthcare programs and home-based care initiatives. Providers in Italy prioritize affordable, easy-to-use devices that support ongoing management of cardiovascular conditions.

Segment Leadership and Growth Trends

 

End Use Segment Analysis: Hospitals (Largest Segment) vs Homecare (Fastest-Growing Segment)

Hospitals dominated the blood pressure monitoring devices market in 2026, accounting for a 54.67% share, supported by the routine need for accurate blood pressure assessment across inpatient care, emergency services, surgical procedures, and chronic disease management. Hospitals rely on established monitoring protocols and clinically validated devices to support timely diagnosis and continuous assessment of patients with cardiovascular and other conditions. The concentration of specialized healthcare professionals and the growing emphasis on regular vital-sign monitoring further reinforce hospitals as a key end-use setting.

Homecare is the fastest-growing segment as blood pressure management increasingly shifts toward convenient monitoring outside conventional clinical environments. The rising prevalence of chronic cardiovascular conditions and greater emphasis on preventive health are encouraging patients and caregivers to monitor blood pressure more regularly at home. Improved device usability and the growing acceptance of self-monitoring also support earlier identification of changes in blood pressure, strengthening demand for home-based monitoring solutions.

Device Type Segment Analysis: Non-Smart/Traditional (Largest Segment) vs Smart (Fastest-Growing Segment)

The non-smart/traditional segment held the largest share of the blood pressure monitoring devices market in 2026, reflecting the continued use of established blood pressure measurement technologies across healthcare facilities and household settings. Their straightforward operation, familiarity among healthcare professionals, and suitability for routine measurements support broad adoption. Reliability and accessibility remain important considerations in blood pressure assessment, particularly where advanced digital connectivity is not essential.

Smart devices are expanding at the fastest pace as consumers and healthcare providers place greater emphasis on connected health monitoring and longitudinal patient management. Digital connectivity can facilitate the recording, organization, and sharing of blood pressure readings, supporting more informed discussions between patients and healthcare professionals. Increasing interest in remote monitoring, personalized care, and technology-enabled disease management is therefore strengthening demand for smart blood pressure monitoring solutions.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End Use	Hospitals, Ambulatory Surgical Centers & Clinics, Homecare	Hospitals	Homecare
Device Type	Non-Smart/Traditional, Smart	Non-Smart/Traditional	Smart
Connectivity	Non-Connected, Connected, Wi-Fi-based, Bluetooth-based	Non-Connected	Connected

Competitive Landscape and Market Positioning

Prominent players in the blood pressure monitoring devices market:

1. Omron Healthcare Co. Ltd. (Japan)

2. Koninklijke Philips N.V. (Netherlands)

3. GE HealthCare Technologies Inc. (United States)

4. Welch Allyn Inc. (United States)

5. A&D Company Limited (Japan)

6. SunTech Medical Inc. (United States)

7. Microlife Corporation (Taiwan)

8. Rossmax International Ltd. (Taiwan)

9. Spacelabs Healthcare Inc. (United States)

10. B. Braun SE (Germany)

The blood pressure monitoring devices market is experiencing increased innovation driven by rising consumer interest in preventive healthcare and connected wellness technologies. Manufacturers are introducing compact, app-enabled, and AI-supported monitoring solutions that enhance usability and tracking accuracy. The growing preference for home-based healthcare monitoring is further encouraging the development of portable and digitally integrated blood pressure monitoring devices.

Industry Development/News

Company Name	Date	Key Development
Tenovi	May-25	Tenovi has launched a cellular-connected blood pressure monitor designed to support remote cardiovascular care and stroke prevention. By enabling continuous monitoring of blood pressure and irregular heart rhythms, the platform allows clinicians to detect hypertension earlier, providing a scalable solution for healthcare providers to manage patient health outcomes remotely.
Huawei	Mar-25	Huawei has officially debuted the Watch D2 in the Indian market, bringing medical-grade blood pressure monitoring to the consumer smartwatch segment. The device utilizes advanced sensors and a specialized integrated mechanism to achieve higher measurement accuracy than conventional optical wearable sensors, marking a shift toward the integration of clinical-grade diagnostics into mainstream wearable technology.
Huawei	Jul-25	Huawei released a global software update for its Watch D2 wearable to optimize its blood pressure monitoring functionality. This update reflects the company’s strategic commitment to expanding its wearable health technology portfolio and improving the real-time cardiovascular data tracking capabilities available to global consumers.
MPR	Jul-25	A new FDA-cleared cuffless blood pressure monitoring device has been introduced as a wearable band capable of continuous 24-hour tracking. This non-invasive, ambulatory solution facilitates improved long-term hypertension management by capturing blood pressure fluctuations across daily and nocturnal cycles, bypassing the limitations associated with traditional cuff-based measurement systems.
CU Denver	Mar-25	Researchers at CU Denver have developed a non-invasive wearable blood pressure monitor utilizing smart technology. The innovation focuses on integrating continuous cardiovascular tracking into portable platforms, supporting the broader transition toward digital health solutions and remote patient monitoring systems aimed at more effective hypertension management.
Frontiers	Oct-24	Research published in Frontiers highlights the validation of a photoplethysmography-based cuffless blood pressure monitor capable of non-invasive tracking. This development marks a significant advancement in sensor-based cardiovascular monitoring, supporting the pipeline for next-generation wearables designed to increase the accessibility and precision of continuous, long-term blood pressure measurement for patients.